Healthcare provider currently forecasting a £15.2m overspend
Increased spend on drugs over the winter months poses a 'huge pressure' to Manx Care's finances.
That's according to the healthcare provider's finance director who provided an update on the organisation's finances at the most recent board meeting.
Earlier this year Manx Care was forecasting an overspend in excess of £18m but its most recent figures show that now stands at £15.2m.
Jackie Lawless says medication is one area that can see rising demand and therefore higher costs at this time of year:
Balthane Roundabout targeted for Spring 2027 completion, says infrastructure minister
Jurby Junk founder dies aged 90
Treasury exploring replacement payment card scheme
Liverpool ferry terminal dispute escalates in House of Keys as minister refuses to publish final cost
Assisted Dying Bill: Health minister writes to MHKs as Ministry of Justice holds legislation under review